In this video, Psych Congress 2020 presenter Timothy Wilens, MD, provides strategies clinicians can use when treating a patient with both attention-deficit/hyperactivity disorder (ADHD) and substance use disorder (SUD).
Psych Congress 2020 cochair Vladimir Maletic, MD, MS, discusses the risks associated with comorbid conditions in patients with attention deficit/hyperactivity disorder (ADHD) and strategies for treating them.
When a patient is newly diagnosed with attention-deficit/hyperactivity disorder (ADHD), is it better to begin treatment with a stimulant or a nonstimulant? Anthony L. Rostain, MD, MA, shares his thoughts in this video.
Stay in the know. Psychiatry and Behavioral Health Learning Network Newsletter